Medifast Inc. (MED) Reports Q4 Miss; Guides Q1
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.00 -0.66%
EPS Growth %: -195.2%
Financial Fact:
Gross Profit: 52.16M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -195.2%
Financial Fact:
Gross Profit: 52.16M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medifast Inc. (NYSE: MED) reported Q4 EPS of $0.23, $0.09 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $63 million versus the consensus estimate of $64.67 million.
Sees Q1 revenue of $73.5-$74 million, versus the consensus of $80.70 million.
Sees Q1 revenue of $73.5-$74 million, versus the consensus of $80.70 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- YYForce outlines 2030 plan to combine human staffing, AI, and robotics
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
